Kineta's research on antiviral drugs attracts $2.8M NIH grant

08/12/2011 | American City Business Journals

The NIH's National Institute of Allergy and Infectious Disease awarded a $2.8 million grant to Kineta to develop drugs against RNA viruses, including hepatitis and flu. "Our goal is to find novel drugs that can treat infections for the long term," said Kristen Bedard, the firm's principal scientist in virology.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN